Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization

Core Insights - Hims & Hers Health, Inc. (HIMS) emphasizes the role of data and AI in creating a personalized healthcare experience, enhancing customer interactions and outcomes [1][6] - The company has launched Labs for tracking biomarkers and is investing in AI to improve clinical decision-making and care personalization [2][6] Company Developments - Hims & Hers introduced Labs, allowing customers to monitor key biomarkers and connect results to actionable plans developed by doctors [2] - The company is enhancing its MedMatch capabilities and AI workflows to improve diagnosis and care quality [6] Market Performance - Hims & Hers shares have increased by 24.2% over the past year, contrasting with a 5.2% decline in the industry [5] - The forward 12-month price-to-sales ratio for HIMS is 2.8X, lower than the industry average of 4.6X but higher than its three-year median of 2.6X [9] Earnings Estimates - The Zacks Consensus Estimate predicts a 77.8% increase in HIMS' earnings per share from 2024 to 2025 [7] - Current estimates for HIMS' earnings per share for the next year are 0.59, reflecting a year-over-year growth of 22.33% [10]